The downgrade from Buy to Neutral by a prominent analyst like Bonnie Herzog at Goldman Sachs could lead to a neutral short-term impact on Kenvue's stock price. The maintenance of the price target at $20 suggests that while the immediate growth prospects might be limited, the valuation is still considered fair. Investors might adopt a wait-and-see approach, leading to limited immediate price movement.